Jupiter Scientist Courtney Miller Named BioFlorida’s Entrepreneur of the Year
Florida’s statewide biotechnology industry organization, BioFlorida, awarded its 2022 Weaver H. Gaines Entrepreneur of the Year award to Courtney Miller, Ph.D.
Posts tagged as
Cancer
Mining Natural Products Reveals Nature’s Method for Building a Cancer Killer
Enediynes can bind and break DNA, leading to cell death. As a result, they have enormous potential as antibiotics and cancer drugs. A new study reveals how nature assembles them.
Outstanding UF Scripps Inventors Recognized by UF Innovate
Two scientists at UF Scripps have been recognized with "Invention of the Year" awards from UF Innovate. Read about their inventions.
Research Spotlight: Chemist targets RNA to attack incurable disease from a new direction
A trailblazing scientist targets ALS, myotonic dystrophy, Parkinson’s, metastatic breast cancer, viral diseases and more by attacking key RNA, preventing disease-causing genes from being expressed in the first place.
RNA Drug Discovery Effort Reveals 1 in 300 Million
The findings show it is possible to substantially accelerate the drug discovery process. The technique opens new doors to treating diseases by targeting their RNA processes, said Disney.
Researchers Discover How Cellular Stress Changes Protein Building
The Karbstein lab has discovered how ribosomes are remodeled in response to stress, altering their protein output.
News & Events
expanding knowledge Lab news from The Wertheim UF Scripps Institute…
Research on Hormone Receptors Advances Understanding of Sensitive Cancers
By distorting estrogen receptor shape in two different ways, compounds offer a two-for-one punch to estrogen-sensitive cancer cells. Kendall Nettles, PhD, (center) meets with two students in his lab, Jacqline Njeri (left) and Charles Min (right). Nettles and colleagues designed drug-like molecules that appear to fight estrogen-sensitive breast cancer in…
Toward Safer Steroids
Scientists devise process for making precision anti-inflammatory medicines with fewer side-effects at UF Scripps Biomedical Research in Jupiter, Florida.
Treating Cancer Drug Resistance May Come at a Cost to Immune System, Study Suggests
Inhibiting the key gene involved in cancer drug resistance could dull the anti-cancer immune response by inhibiting a type of T lymphocytes, a study from Sundrud lab finds.
